SpringerBriefs in Pharmaceutical Science & Drug Development

Turner, J. Rick

This Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.

Details

Published by: Springer

Publication Date: 2011-10-13

Format: Paperback

ISBN-13: 9781461416616

DOI: 10.1007/978-1-4614-1662-3

Dimensions: 235cm x155cm

Pages: 61